Skip to main content
. 2009 Oct;23(10):815–824. doi: 10.1089/apc.2009.0048

Table 1.

Demographic, Laboratory, and Clinical Factors in Relation to the Risk of Presence of Coronary Plaques

 
 
Presence of coronary plaques
 
Characteristic Total (n = 176) No (n = 124) Yes (n = 52) p value
Age (years) 44.2 (39.9–47.3) 42.9 (38.6–46.0) 47.3 (43.5–49.5) <0.0001
Female (%) 36.9 44.4 19.2 0.002
Family history of CAD (%) 23.8 22.6 26.9 0.54
CD4 (count/mm3) 344 (177–498) 346 (177–516) 314 (216–498) 0.67
Plasma HIV viral load (copies/mL) 581 (30–14789) 638 (30–22771) 300 (30–12852) 0.60
Cocaine use (%) 90.9 88.7 96.2 0.12
Cocaine use ≥15 y (%) 34.1 27.4 50.0 0.004
Cigarette smoking (%) 86.4 85.5 88.5 0.60
Cigarette smoking ≥15 y (%) 77.8 75.0 84.6 0.53
Alcohol use (%) 89.8 88.7 92.3 0.47
hs-CRP ≥2 mg/dL (%) 41.7 42.7 39.2 0.67
hsCRP (mg/dL) 1.5 (0.6–4.1) 1.5 (0.6–4.4) 1.5 (0.6–3.4) 0.62
Systolic BP (mm Hg) 111 (103–120) 111 (103–119) 111 (108–121) 0.24
Diastolic BP (mm Hg) 74 (69–81) 73 (69–81) 77 (66–82) 0.44
Glucose (mg/dL) 84 (78–90) 84 (78–89) 86 (80–94) 0.14
BMI (kg/m2) 23.8 (21.5–27.3) 24.1 (21.9–27.3) 23.7 (21.4–27.2) 0.71
Total cholesterol (mg/dL) 161 (142–186) 158 (137–181) 170 (157–196) 0.005
LDL-C (mg/dL) 86 (70–107) 81 (67–107) 94 (80–113) 0.019
HDL-C (mg/dL) 49 (38–60) 48 (38–59) 51 (35–63) 0.80
Triglycerides (mg/dL) 107 (73–151) 100 (72–138) 132 (78–173) 0.025
Years of cocaine use 13 (5–20) 11 (5–17) 16 (6–22) 0.013
Duration of ART use (mo)        
 NRTIs 0 (0–12) 0 (0–12) 0 (0–30) 0.048
 NNRTIs 0 (0–0) 0 (0–0) 0 (0–15) 0.0017
 PIs 0 (0–12) 0 (0–6) 0 (0–24) 0.06
 All 3 (0–24) 1 (0–20) 19 (0–47) 0.001
Coronary calcification (%) 25.6 4.8 75.0 <0.0001
Framingham risk score 3.5 (2.0–5.0) 3 (2–4) 5 (4–8) <0.0001
Framingham score ≥3.0 (%) 69.5 61.3 90 <0.0001
a

Median (interquartile range) for continuous variables, proportion (%) for categorical variables.

CAD, coronary artery disease; CD4, CD4 cell count; HIV, human immunodeficiency virus; hs-CRP, high sensitivity C-reactive protein; BP, blood pressure; glucose, fasting glucose; BMI, body mass index; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Framingham score, Framingham risk score; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, nonnucleoside reverse transcriptase inhibitors; PIs, protease inhibitors; ART, antiretroviral therapy.